Publicacions (17) Publicacions de Elena Panizo Morgado

2024

  1. Re-irradiation for progressive Diffuse Intrinsic Pontine Glioma (DIPG): The Spanish experience

    EJC Paediatric Oncology, Vol. 4

2023

  1. Hospital-based proton therapy implementation during the COVID pandemic: early clinical and research experience in a European academic institution

    Clinical and Translational Oncology, Vol. 25, Núm. 5, pp. 1268-1276

  2. Identification of germline cancer predisposition variants in pediatric sarcoma patients from somatic tumor testing

    Scientific Reports, Vol. 13, Núm. 1

  3. Neurocognitive outcomes in pediatric brain tumors after treatment with proton versus photon radiation: a systematic review and meta-analysis

    World Journal of Pediatrics, Vol. 19, Núm. 8, pp. 727-740

2022

  1. Case Report: The Value of Genomic Analysis in a Case of Megakaryoblastic Leukemia With Atypical Initial Manifestation

    Frontiers in Pediatrics, Vol. 10

  2. Neuroblastoma in Spain: Linking the national clinical database and epidemiological registries – A study by the Joint Action on Rare Cancers

    Cancer Epidemiology, Vol. 78

2021

  1. Clinical value of NGS genomic studies for clinical management of pediatric and young adult bone sarcomas

    Cancers, Vol. 13, Núm. 21

  2. Interpretación de las pruebas de coagulación

    Pediatria Integral, Vol. 25, Núm. 5, pp. 265.e1-265.e11

2020

  1. Beta-Spectrin Deletion Responsible for Hereditary Spherocytosis: When New Technologies Are Not the Key to Success

    Journal of Pediatric Hematology/Oncology, Vol. 42, Núm. 7, pp. e686-e688

  2. Somatic and germline analysis of a familial Rothmund–Thomson syndrome in two siblings with osteosarcoma

    npj Genomic Medicine, Vol. 5, Núm. 1

2015

  1. Factors influencing the use of thromboprophylaxis in cancer outpatients in clinical practice: A prospective study

    Thrombosis Research, Vol. 136, Núm. 6, pp. 1145-1148

2013

  1. High incidence of venous thromboembolism despite electronic alerts for thromboprophylaxis in hospitalised cancer patients

    Thrombosis and Haemostasis, Vol. 110, Núm. 1, pp. 184-190

2011

  1. Economic impact of an electronic alert system to prevent venous thromboembolism in hospitalised patients

    Journal of Thrombosis and Haemostasis, Vol. 9, Núm. 6, pp. 1108-1115

2008

  1. Maintained effectiveness of an electronic alert system to prevent venous thromboembolism among hospitalized patients

    Thrombosis and Haemostasis, Vol. 100, Núm. 4, pp. 699-704

  2. Systemic lupus erythematosus and Franklin's disease: When the somatic mutation mechanism makes a mistake

    Rheumatology

2007

  1. Parvovirus B19 acute infection and a reactivation of cytomegalovirus and herpesvirus 6 in a chronic myeloid leukemia patient during treatment with dasatinib (BMS-354825)

    Leukemia and Lymphoma, Vol. 48, Núm. 12, pp. 2461-2464

  2. Treatment of antiphospholipid syndrome

    Revista de medicina de la Universidad de Navarra, Vol. 51, Núm. 4, pp. 38-41